United States · FDA National Drug Code directory

TACLONEX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 50222-501_5d56e57e-6b91-4916-96d8-6dca1af7487d
Product NDC: 50222-501
Form: SUSPENSION
Composition / generic term: calcipotriene and betamethasone dipropionate
Labeler: LEO Pharma Inc.
Marketing category: NDA
Marketing start / end (source format): 20080601
Source listing expiry: 20261231

Source-listed ingredients

CALCIPOTRIENE HYDRATE — 50 ug/g
BETAMETHASONE DIPROPIONATE — .5 mg/g

These values do not establish equivalence or a dose recommendation.

Packages

40 CARTON in 1 CASE (50222-501-06) / 1 BOTTLE in 1 CARTON / 60 g in 1 BOTTLE · 50222-501-06
10 PACKAGE in 1 BOX (50222-501-66) / 2 BOTTLE in 1 PACKAGE / 60 g in 1 BOTTLE · 50222-501-66

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →